China Universal Asset Management »

Structure Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $503k 12k 43.89
2024-06-30 $226k 5.8k 39.27
2024-03-31 $402k 9.4k 42.86
2023-12-31 $177k 4.3k 40.76
2023-09-30 $71k 1.4k 50.42
2023-06-30 $1.1M 27k 41.57

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Structure Therapeutics

Capital Research Global Investors
Henderson Group
Driehaus Capital Management
Federated Investors
BVF
T. Rowe Price Associates
RA Capital Management
Citadel Advisors
Logos Global Management
Capital Research and Management Company - Division 3
Point72 Asset Management
Octagon Capital Advisors
Vestal Point Capital
Rock Springs Capital Management
Deep Track Capital

View all funds holding Structure Therapeutics